{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:37:04Z","timestamp":1789522624709,"version":"build-2803163510"},"reference-count":80,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health (NIH)","award":["RO1 HD094378"],"award-info":[{"award-number":["RO1 HD094378"]}]},{"name":"National Institutes of Health (NIH)","award":["RO1 ES028615"],"award-info":[{"award-number":["RO1 ES028615"]}]},{"name":"National Institutes of Health (NIH)","award":["U54 MD007602"],"award-info":[{"award-number":["U54 MD007602"]}]},{"name":"National Institutes of Health (NIH)","award":["RO1 HD094380"],"award-info":[{"award-number":["RO1 HD094380"]}]},{"name":"National Institutes of Health (NIH)","award":["HD106285"],"award-info":[{"award-number":["HD106285"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Uterine leiomyosarcoma (uLMS) is the most frequent subtype of uterine sarcoma that presents a poor prognosis and high rates of recurrence and metastasis. The origin and molecular mechanism underlying and driving its clinical and biological behavior remain largely unknown. Recently, we and others have revealed the role of microRNAs, DNA methylation, and histone modifications in contributing to the pathogenesis of uLMS. However, the connection between reversible m6A RNA methylation and uLMS pathogenesis remains unclear. In this study, we assessed the role and mechanism of FTO m6A RNA demethylase in the pathogenesis of uLMS. Immunohistochemistry analysis revealed that the levels of RNA demethylases FTO and ALKBH5 were aberrantly upregulated in uLMS tissues compared to adjacent myometrium with a significant change by histochemical scoring assessment (p &lt; 0.01). Furthermore, the inhibition of FTO demethylase with its small, potent inhibitor (Dac51) significantly decreased the uLMS proliferation dose-dependently via cell cycle arrest. Notably, RNA-seq analysis revealed that the inhibition of FTO with Dac51 exhibited a significant decrease in cell-cycle-related genes, including several CDK members, and a significant increase in the expression of CDKN1A, which correlated with a Dac51-exerted inhibitory effect on cell proliferation. Moreover, Dac51 treatment allowed the rewiring of several critical pathways, including TNF\u03b1 signaling, KRAS signaling, inflammation response, G2M checkpoint, and C-Myc signaling, among others, leading to the suppression of the uLMS phenotype. Moreover, transcription factor (TF) analyses suggested that epitranscriptional alterations by Dac51 may alter the cell cycle-related gene expression via TF-driven pathways and epigenetic networks in uLMS cells. This intersection of RNA methylation and other epigenetic controls and pathways provides a framework to better understand uterine diseases, particularly uLMS pathogenesis with a dysregulation of RNA methylation machinery. Therefore, targeting the vulnerable epitranscriptome may provide an additional regulatory layer for a promising and novel strategy for treating patients with this aggressive uterine cancer.<\/jats:p>","DOI":"10.3390\/ijms24097957","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:27:56Z","timestamp":1682648876000},"page":"7957","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-8946","authenticated-orcid":false,"given":"Qiwei","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-4447","authenticated-orcid":false,"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: A review","volume":"116","author":"Prat","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","article-title":"Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial","volume":"109","author":"Hensley","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/gyno.1996.0185","article-title":"Uterine Leiomyosarcoma: Analysis of Treatment Failures and Survival","volume":"62","author":"Gadducci","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"De Almeida, B.C., dos Anjos, L.G., Dobroff, A.S., Baracat, E.C., Yang, Q., Al-Hendy, A., and Carvalho, K.C. (2022). Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102567"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment","volume":"43","author":"Yang","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m6A RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3389\/fcell.2021.617172","article-title":"RNA Demethylase FTO Mediated RNA m6A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion","volume":"9","author":"Qiu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","article-title":"Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5\u2032 Sites","volume":"8","author":"Schwartz","year":"2014","journal-title":"Cell Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.3419","article-title":"RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding","volume":"24","author":"Knuckles","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-methyladenosine Modulates Messenger RNA Translation Efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.apsb.2021.08.028","article-title":"A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities","volume":"12","author":"Xie","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41419-022-04503-7","article-title":"N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m(6)A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"681280","DOI":"10.3389\/fonc.2021.681280","article-title":"N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.7150\/ijbs.77774","article-title":"FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/cam4.5054","article-title":"N(6)-methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion","volume":"12","author":"Wang","year":"2022","journal-title":"Cancer Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41388-022-02306-w","article-title":"RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner","volume":"41","author":"Tan","year":"2022","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13578-022-00798-3","article-title":"m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer","volume":"12","author":"Duan","year":"2022","journal-title":"Cell Biosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111894","DOI":"10.1016\/j.yexcr.2020.111894","article-title":"FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13","volume":"389","author":"Liu","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1002\/ctm2.772","article-title":"FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD\/PARP1","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","article-title":"FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner","volume":"30","author":"Xu","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.2147\/IJGM.S339095","article-title":"The RNA N6-Methyladenosine Demethylase FTO Promotes Head and Neck Squamous Cell Carcinoma Proliferation and Migration by Increasing CTNNB1","volume":"ume 14","author":"Zhang","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41420-021-00724-5","article-title":"FTO promotes tumour proliferation in bladder cancer via the FTO\/miR-576\/CDK6 axis in an m6A-dependent manner","volume":"7","author":"Zhou","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1002\/ctm2.310","article-title":"FTO modifies the m6A level of MALAT and promotes bladder cancer progression","volume":"11","author":"Tao","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/15476286.2020.1841458","article-title":"FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway","volume":"18","author":"Zhang","year":"2021","journal-title":"RNA Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3892\/ol.2020.11673","article-title":"Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer","volume":"20","author":"Ye","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2019.03.093","article-title":"The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA","volume":"512","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbrc.2018.05.175","article-title":"m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression","volume":"502","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","article-title":"RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3","volume":"18","author":"Niu","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12935-019-1045-1","article-title":"The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells","volume":"19","author":"Zou","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"113585","DOI":"10.1016\/j.yexcr.2023.113585","article-title":"FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4\/Hippo\/YAP1\/TAZ pathway","volume":"427","author":"Huang","year":"2023","journal-title":"Exp. Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1111\/jcmm.15228","article-title":"RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway","volume":"24","author":"Jiang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"153042","DOI":"10.1016\/j.prp.2020.153042","article-title":"FTO accelerates ovarian cancer cell growth by promoting proliferation, inhibiting apoptosis, and activating autophagy","volume":"216","author":"Zhao","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7150\/thno.77441","article-title":"ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer","volume":"13","author":"Sun","year":"2023","journal-title":"Theranostics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1021\/acs.jmedchem.1c02075","article-title":"Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents","volume":"65","author":"Huff","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1080\/14756366.2022.2098954","article-title":"Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer","volume":"37","author":"Qin","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"You, Y., Fu, Y., Huang, M., Shen, D., Zhao, B., Liu, H., Zheng, Y., and Huang, L. (2022). Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105815"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/1878-0261.13050","article-title":"EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression","volume":"15","author":"Lee","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41419-020-03031-6","article-title":"Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_44","first-page":"3203","article-title":"miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma","volume":"19","author":"He","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional Addiction in Cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1038\/s41388-020-01459-w","article-title":"Core transcriptional regulatory circuitries in cancer","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Lasman, L., Hanna, J.H., and Novershtern, N. (2020). Role of m6A in Embryonic Stem Cell Differentiation and in Gametogenesis. Epigenomes, 4.","DOI":"10.3390\/epigenomes4010005"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.stemcr.2018.01.014","article-title":"An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal","volume":"10","author":"Fiorenzano","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Fiorenzano, A., Pascale, E., Patriarca, E.J., Minchiotti, G., and Fico, A. (2019). LncRNAs and PRC2: Coupled Partners in Embryonic Stem Cells. Epigenomes, 3.","DOI":"10.3390\/epigenomes3030014"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/15384101.2022.2110439","article-title":"DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis","volume":"22","author":"Han","year":"2022","journal-title":"Cell Cycle"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.21037\/atm-21-5975","article-title":"Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism","volume":"9","author":"Chen","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"664242","DOI":"10.3389\/fonc.2021.664242","article-title":"miR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer","volume":"11","author":"Luo","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41419-021-03717-5","article-title":"The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression","volume":"12","author":"Peng","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yang, Q., Falahati, A., Khosh, A., Mohammed, H., Kang, W., Corach\u00e1n, A., Bariani, M.V., Boyer, T.G., and Al-Hendy, A. (2022). Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma. Cells, 11.","DOI":"10.3390\/cells11233801"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1021\/acs.jmedchem.2c00848","article-title":"Structure\u2013Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000526752","article-title":"Inhibition of Hypothalamic FTO Activates STAT3 Signal through ERK1\/2 Associated with Reductions in Food Intake and Body Weight","volume":"113","author":"Hu","year":"2023","journal-title":"Neuroendocrinology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1002\/1878-0261.13319","article-title":"MYC and therapy resistance in cancer: Risks and opportunities","volume":"16","author":"Donati","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","article-title":"Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance","volume":"83","author":"Fatma","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e970480","DOI":"10.4161\/23723548.2014.970480","article-title":"To live or let die\u2013complexity within the E2F1 pathway","volume":"2","author":"Roworth","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"599332","DOI":"10.3389\/fmolb.2020.599332","article-title":"E2F1: Cause and Consequence of DNA Replication Stress","volume":"7","author":"Fouad","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_63","first-page":"757","article-title":"A comprehensive review of the roles of E2F1 in colon cancer","volume":"10","author":"Fang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/1568009616666160216130755","article-title":"E2F1 and NF-kappaB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets","volume":"16","author":"Huang","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.7150\/ijbs.62517","article-title":"Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells","volume":"17","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41388-021-01661-4","article-title":"MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma","volume":"40","author":"Ke","year":"2021","journal-title":"Oncogene"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2174\/1871520620666201106085227","article-title":"Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells","volume":"21","author":"Tian","year":"2021","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1541-7786.MCR-20-0197","article-title":"Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes","volume":"18","author":"Hemming","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jcp.1111","article-title":"Sp1 and kr\u00fcppel-like factor family of transcription factors in cell growth regulation and cancer","volume":"188","author":"Black","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.2147\/CMAR.S200907","article-title":"Sp1 contributes to radioresistance of cervical cancer through targeting G2\/M cell cycle checkpoint CDK1","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/sj.onc.1205211","article-title":"Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells","volume":"21","author":"Grinstein","year":"2002","journal-title":"Oncogene"},{"key":"ref_72","first-page":"2825","article-title":"Interaction between Sp1 and cell cycle regulatory proteins is important in transactivation of a differentiation-related gene","volume":"60","author":"Opitz","year":"2000","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuint.2014.03.012","article-title":"The interplay between microRNAs and histone deacetylases in neurological diseases","volume":"77","author":"Bourassa","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17590914211042220","DOI":"10.1177\/17590914211042220","article-title":"Identification of miRNAs That Mediate Protective Functions of Anti-Cancer Drugs During White Matter Ischemic Injury","volume":"13","author":"Baltan","year":"2021","journal-title":"ASN Neuro"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Klieser, E., Urbas, R., Swierczynski, S., St\u00e4ttner, S., Primavesi, F., J\u00e4ger, T., Mayr, C., Kiesslich, T., Di Fazio, P., and Helm, K. (2018). HDAC-Linked \u201cProliferative\u201d miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092781"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.aay6018","article-title":"N6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription","volume":"367","author":"Liu","year":"2020","journal-title":"Science"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Yang, Q., Bariani, M.V., Falahati, A., Khosh, A., Lastra, R.R., Siblini, H., Boyer, T.G., and Al-Hendy, A. (2022). The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma. Cells, 11.","DOI":"10.3390\/cells11142160"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ram, S., Vizcarra, P., Whalen, P., Deng, S., Painter, C.L., Jackson-Fisher, A., Pirie-Shepherd, S., Xia, X., and Powell, E.L. (2021). Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images. PLoS ONE, 16.","DOI":"10.1101\/2021.01.06.425539"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"Voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: A comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7957\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:24:47Z","timestamp":1760124287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":80,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24097957"],"URL":"https:\/\/doi.org\/10.3390\/ijms24097957","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]}}}